CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
Surgical Congress to focus on new patient data supporting the Ross heart reconstruction procedure and the use of SynerGraft processed human heart valves in the Ross procedure ATLANTA, Oct. 7 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ), a biomaterials, medical ...Covance to Present at the Drug Information Association's 45th Annual Meeting
...evelopment "EDC Front to Back: Streamline Processes End-to-End for True Operational Benefit" 3:30 p.m. | Speaker: ross Rothmeier, senior director, EDC portfolio, clinical development services June 23, 2009: "Corrective Action and Preventiv...Kendle Expands Asia/Pacific Operations with Opening of Offices in Kuala Lumpur, Bangkok and Manila
...able advantage. "With more than half of the world's population, Asia offers an abundance of patients in nearly every therapeutic area," added Dr. ross Horsburgh, Vice President, Global Clinical Development - Asia/Pacific. "Furthermore, governments have highlighted biopharmaceutical development as a ...SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC
...participates in commercially-relevant agricultural research and we are the leading early-stage venture capital fund-of-fund investor in Alberta," said ross Bricker, AVAC President and CEO. "Since 1997, with the support of the Alberta and Canadian Governments, we have invested in and provided guidance to o...Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team
... Parker received his undergraduate degree in Biological Sciences from the University of Chicago , an MBA from the University of Michigan Stephen M. ross School of Business, and attended the Georgetown University School of Medicine . Michael G. Kauffman, M.D., Ph.D. Chief Medical Officer ...Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
...l advisory board, Dr. Bruce D. Spiess, M.D., FAHA - Professor Anesthesiology and Emergency Medicine, VCURES/ VCU Med Center Richmond, Virginia and Dr. ross Bullock, M.D. Ph.D.- Professor of Neurosurgery, University of Miami , Miami, Florida. The three will be in Switzerland in connection with the c...LAB Research announces changes to its Board of Directors
...nal Corporation, Executive Vice President and Group President, Healthcare Products Services at Cardinal Health and Vice President and General Manager, ross Products for Abbott Laboratories. "I am impressed with the timely execution and completion of the growth and development strategy put forward by the...Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
...d, serving most recently as Vice President, Marketing. In previous positions, Mr. Franklin filled marketing roles with Biovail Pharmaceuticals and the ross Products Division of Abbott Labs. In these positions, he launched and managed products throughout various lifecycle phases in multiple therapeutic cat...ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action
...s results we have obtained." She further explains that these results indicate that AAGP(TM) could be both an adhesion inhibitor and an anti-oxidant. ross Senior, President and CEO of ProtoKinetix, said, "The control of inflammation is of vital importance to the treatment of a number of immune complex me...Cepheid to Webcast Upcoming Financial Presentations
...n the biothreat market. CONTACTS: For Media Inquiries: For Investor Inquiries: Jared Tipton Jacquie ross Cepheid Corporate Communications Cepheid Investor Relations Tel: (408) 400-8377 Tel: (408) 400-8329 jared.tipton@cepheid...Cepheid Reports Third Quarter Revenue of $44.9 Million
...why results might differ. CONTACTS: For Media Inquiries: For Investor Inquiries: Jared Tipton Jacquie ross Cepheid Corporate Communications Cepheid Investor Relations Tel: (408) 400 8377 Tel: (408) 400 8329 jared.tipton@cepheid.c...Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA
... Inquiries: Jared Tipton Cepheid Corporate Communications 408-400-8377 jared.tipton@cepheid.com For Cepheid Investor Inquiries: Jacquie ross Cepheid Investor Relations 408-400-8329 jacquie.ross@cepheid.com ...ProtoKinetix Partners with OTC Financial Network to Increase Shareholder Base
...TCFN to increase our market awareness and widen our shareholder base," said ross L. Senior, President and CEO of ProtoKinetix Inc. "We are excited to be wor...Company's filings with the Securities and Exchange Commission. CONTACT ross L. Senior, LLB - President and CEO Company Office: ...Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
...e biothreat market. CONTACTS: For Media Inquiries: For Investor Inquiries: Jared Tipton Jacquie ross Cepheid Corporate Communications Cepheid Investor Relations Tel: (408) 400 8377 Tel: (408) 400 8329 jared.tipton@cep...SoluBest Appoints Michael Sheckler, MBA, as CEO
...gi-bin/prnh/20080910/NEW068LOGO ) Mr. Sheckler began his career with the ross Division of Abbott Laboratories, selling nutritional and pharmaceutical pro...t and product launch plans for several line extensions. Mr. Sheckler left ross in 1999 to join Bespak, Inc., a drug delivery technology company, where he ...On-Line Medicare Advisor Saves Seniors Time, Hassle and Money
...r's call center at 877-900-4824. "The rising costs of prescription drugs is a real burden for seniors on a fixed income," says Experion Systems CEO, ross Blair. He explains, "PlanPrescriber allows seniors to switch to the optimal plan based on their individual needs. Seniors can typically save 25% to 50...Axial Biotech appoints new Vice President of Strategic Initiatives
...in the spine care market, announced today that Joe ross has joined the executive management team as the co...dent of Strategic Initiatives. In this new role, ross will oversee Axial Biotech's global efforts to ide...of today, and those anticipated in the future. Mr. ross is uniquely qualified to drive this effort given h...Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
... Appoints Stephen ross Senior Vice President of Commercial Operations and...day the addition of two key executives. Stephen A. ross was appointed Senior Vice President of Commercial ... to meet the needs of our growing business." Mr. ross previously served as Senior Vice President, Sales ...Cepheid to Webcast Upcoming Financial Presentations
...e biothreat market. CONTACTS: For Media Inquiries: For Investor Inquiries: Jared Tipton Jacquie ross Cepheid Corporate Communications Cepheid Investor Relations Tel: (408) 400-8377 Tel: (408) 400-8329 jared.tipton@cep...Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target
...agents and positions Inovio/VGX, based on further development progress, to move toward the same valuation arena as other gene therapy companies," said ross Silver, Director of Research for Vista Partners. For more information and to download the free report, please visit the Vista Partners website at htt...Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP)
...TM) sometime in the 3rd quarter of 2008 and we expect FDA approval of Delayed Release (DR) Cysteamine for the treatment of cystinosis in 2010," stated ross Silver, Director of Research for Vista Partners. For more information and to download the report for free, please visit the Vista Partners website at ...Cepheid Reports Second Quarter Revenue of $42.1 Million
...a Inquiries: Jared Tipton Cepheid Corporate Communications Tel: (408) 400 8377 jared.tipton@cepheid.com For Investor Inquiries: Jacquie ross Cepheid Investor Relations Tel: (408) 400 8329 jacquie.ross@cepheid.com CEPHEID CONDENSED CONSOLIDA...Cepheid to Webcast Analyst Event
...a Inquiries: Jared Tipton Cepheid Corporate Communications Tel: (408) 400 8377 jared.tipton@cepheid.com For Investor Inquiries: Jacquie ross Cepheid Investor Relations Tel: (408) 400 8329 jacquie.ross@cepheid.com ...Organizational Changes at Silence Therapeutics
... has been appointed Senior Independent Non-Executive Director. On behalf of the Board of Silence Therapeutics plc, Jeremy Curnock Cook said: "Iain ross was responsible for the financial and operational turnaround of the Company from July 2004 until July 2007, and the Silence Board of Directors is conf...Vista Partners Initiates Coverage on MediciNova Inc. (Nasdaq: MNOV)
...n the United States and over 2.5 million globally. Worldwide sales of drugs used in the treatment of MS were approximately $7.2 billion in 2006," said ross Silver, Director of Research for Vista Partners. For more information and to download the report, please visit the Vista Partners website at http://w...Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
...ents in the biothreat market. For Media Inquiries: For Investor Inquiries: Jared Tipton Jacquie ross Cepheid Corporate Communications Cepheid Investor Relations Tel: (408) 400 8377 Tel: (408) 400 8329 jared.tipton@c...Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
...its other drug candidates. For more information, please visit the Company's website at http://www.synvista.com . Contact: Vista Partners LLC ross Silver (310) 744-5268 info@vistap.com http://www.vistap.com ...Method to deliver molecules within embryonic stem cells improves differentiation
...hanism of presentation. The research team which also includes graduate students Richard Carpenedo and Andrs Bratt-Leal and undergraduate students ross Marklein and Scott Seaman fabricated biodegradable polymer microspheres that could contain growth factors, proteins or other small molecules. McDe...Vista Partners Updates Coverage; Maintains $3.20 Target Price
...results to a data management system, enabling the test administrator to easily manage their drug testing program. Contact: Vista Partners LLC ross Silver (415) 738-6229 info@vistap.com http://www.vistap.com ...